Novo Integrated Sciences Inc (NVOS)
0.523
-0.08
(-12.82%)
USD |
NASDAQ |
May 03, 16:00
0.5235
0.00 (0.00%)
After-Hours: 20:00
Novo Integrated Sciences Revenue (Quarterly): 3.171M for Feb. 29, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 3.171M |
| November 30, 2023 | 3.891M |
| August 31, 2023 | 3.303M |
| May 31, 2023 | 3.293M |
| February 28, 2023 | 2.556M |
| November 30, 2022 | 3.419M |
| August 31, 2022 | -8.145M |
| May 31, 2022 | 13.85M |
| February 28, 2022 | 2.869M |
| November 30, 2021 | 3.162M |
| August 31, 2021 | 2.693M |
| May 31, 2021 | 2.381M |
| February 28, 2021 | 2.076M |
| November 30, 2020 | 2.156M |
| Date | Value |
|---|---|
| August 31, 2020 | 1.845M |
| May 31, 2020 | 1.038M |
| February 29, 2020 | 2.429M |
| November 30, 2019 | 2.549M |
| August 31, 2019 | 2.420M |
| May 31, 2019 | 2.490M |
| February 28, 2019 | 2.200M |
| November 30, 2018 | 2.312M |
| August 31, 2018 | 2.172M |
| May 31, 2018 | 2.323M |
| February 28, 2018 | 2.146M |
| November 30, 2017 | 2.254M |
| August 31, 2017 | 2.220M |
| May 31, 2017 | 2.09M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-8.145M
Minimum
Aug 2022
13.85M
Maximum
May 2022
2.672M
Average
2.553M
Median
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 5.698M |
| Astrana Health Inc | 353.04M |
| Cryo-Cell International Inc | 7.852M |
| P3 Health Partners Inc | 346.86M |
| Biote Corp | 45.70M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.746M |
| Total Expenses (Quarterly) | 4.710M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | 12.29M |
| Gross Profit Margin (Quarterly) | 41.76% |
| Profit Margin (Quarterly) | -86.61% |
| Earnings Yield | -122.4% |
| Normalized Earnings Yield | -129.94 |